Tag: Secure

Cytos to Secure up to CHF 37M to Advance Phase II Asthma ImmunotherapyGenetic Engineering NewsThe funds will enable Cytos to conduct a global multicenter Phase IIb trial with its lead product CYT003-QbG10 in patients suffering from allergic asthma as well as to advance the rest of its pipeline. This transaction completes the financial …Cytos revives…